American Elements Logo and U.S. Registered Trademark
Lutetium Trifluoromethanesulfonate
(CF3SO3)3Lu
Product
Product Code
Order or Specifications
99% Lutetium Trifluoromethanesulfonate
LU-CFS-02
 Contact American Elements
99.5% Lutetium Trifluoromethanesulfonate
LU-CFS-025
 Contact American Elements
99.9% Lutetium Trifluoromethanesulfonate
LU-CFS-03
 Contact American Elements
99.95% Lutetium Trifluoromethanesulfonate
LU-CFS-035
 Contact American Elements
99.99% Lutetium Trifluoromethanesulfonate
LU-CFS-04
 Contact American Elements
99.999% Lutetium Trifluoromethanesulfonate
LU-CFS-05
 Contact American Elements
Lutetium Trifluoromethanesulfonate is one of numerous organo-metallic compounds sold by American Elements under the tradename AE Organo-Metallics™ for uses requiring non-aqueous solubility such as recent solar energy and water treatment applications. Similar results can sometimes also be achieved with Nanoparticles (also see Nanotechnology and Quantum Dots) and by thin film deposition. Note American Elements additionally supplies many materials as solutions. Lutetium Trifluoromethanesulfonate is generally immediately available in most volumes. High purity, submicron and nanopowder forms may be considered. Additional technical, research and safety information is available.

Lutetium is a Block F, Group 3, Period 6 element. The electronic configuration is [Xe]4f155d16s2. In its elemental form lutetium's CAS number is 7439-94-3. The lutetium atom has a radius of 171.8.pm and it's Van der Waals radius is unknown. Lutetium is the last member of the rare earth series. Lutetium is available as metal and compounds with purities from 99% to 99.999% (ACS grade to ultra-high purity); metals in the form of foil, sputtering target, and rod, and compounds as submicron and nanopowder. Unlike most rare earths it lacks a magnetic moment. It also has the smallest metallic radius of any rare earth.

Formula CAS No. Appearance Molecular Weight
(CF3SO3)3Lu 126857-69-0 622.17
PRODUCT CATALOG Submicron & Nanopowder Tolling Ultra High Purity Sputtering Target Crystal Growth Rod, Plate, Powder, etc.
© 2001-2008. American Elements is a U.S. Registered Trademark. All rights reserved.
This website and all pages, designs, concepts, logos, and color schemes herein are
the copyrighted proprietary rights and intellectual property of American Elements.

 

Recent Research & Development for Lutetium

  • Comparison of four depth-encoding PET detector modules with wavelength shifting (WLS) and optical fiber read-out. Phys Med Biol. 2008 Apr 7;53(7):1829-42. Epub 2008 Mar 10.

  • Rare-Earth Metal Complexes Supported by 1,omega-Dithiaalkanediyl-Bridged Bis(phenolato) Ligands: Synthesis, Structure, and Heteroselective Ring-Opening Polymerization of rac-Lactide. Inorg Chem. 2008 Mar 4; [Epub ahead of print]

  • Virtual-pinhole PET. J Nucl Med. 2008 Mar;49(3):471-9. Epub 2008 Feb 20.

  • Benefit of time-of-flight in PET: experimental and clinical results. J Nucl Med. 2008 Mar;49(3):462-70. Epub 2008 Feb 20.

  • Target burn-up corrected specific activity of (177)Lu produced via (176)Lu(n, gamma) (177)Lu nuclear reactions. Appl Radiat Isot. 2008 Feb 15; [Epub ahead of print]

  • Production of 177Lu at the new research reactor FRM-II: Irradiation yield of 176Lu(n,gamma)177Lu. Appl Radiat Isot. 2008 Feb;66(2):147-51. Epub 2007 Sep 1.

  • Lutetium(III)-dependent self-assembly study of ciliate Euplotes octocarinatus centrin. J Inorg Biochem. 2008 Feb;102(2):268-77. Epub 2007 Sep 7.

  • Rational design and generation of a bimodal bifunctional ligand for antibody-targeted radiation cancer therapy. J Med Chem. 2008 Jan 10;51(1):118-25. Epub 2007 Dec 7.

  • Agonist-antagonist dilemma in molecular imaging: evaluation of a monomolecular multimodal imaging agent for the somatostatin receptor. Bioconjug Chem. 2008 Jan;19(1):192-200. Epub 2007 Nov 20.

  • A feasibility study of a prototype PET insert device to convert a general-purpose animal PET scanner to higher resolution. J Nucl Med. 2008 Jan;49(1):79-87. Epub 2007 Dec 12.

  • Syntheses and structures of mononuclear lutetium imido complexes with very short Lu-N bonds. Chem Commun (Camb). 2007 Dec 21;(47):5007-9. Epub 2007 Sep 27.

  • A comparison between radioimmunotherapy and hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis of colonic origin in rats. Ann Surg Oncol. 2007 Nov;14(11):3274-82. Epub 2007 Jul 25.

  • Radiolabelling of glucose-Tyr3-octreotate with 125I and analysis of its metabolism in rats: comparison with radiolabelled DOTA-Tyr3-octreotate. Anticancer Res. 2007 Nov-Dec;27(6B):3941-6.

  • Absolute quantification of myocardial blood flow with 13N-ammonia and 3-dimensional PET. J Nucl Med. 2007 Nov;48(11):1783-9. Epub 2007 Oct 17.

  • Syntheses, structures, magnetism, and optical properties of lutetium-based interlanthanide selenides. Inorg Chem. 2007 Oct 29;46(22):9213-20. Epub 2007 Oct 3.

  • C-H activation motivated by N,N'-diisopropylcarbodiimide within a lutetium complex stabilized by an amino-phosphine ligand. Dalton Trans. 2007 Oct 10;(38):4252-4. Epub 2007 Jul 25.

  • Effects of treatment with (177)Lu-DOTA-Tyr(3)-octreotate on uptake of subsequent injection in carcinoid-bearing nude mice. Cancer Biother Radiopharm. 2007 Oct;22(5):644-53.

  • Imaging of weak-source distributions in LSO-based small-animal PET scanners. J Nucl Med. 2007 Oct;48(10):1692-8. Epub 2007 Sep 14.

  • High resolution gamma ray tomography scanner for flow measurement and non-destructive testing applications. Rev Sci Instrum. 2007 Oct;78(10):103704.

  • Lutetium alkyl and hydride complexes in a non-cyclopentadienyl coordination environment. Dalton Trans. 2007 Sep 28;(36):4095-102. Epub 2007 Aug 2.

 

 

 

 

American Elements Products can also be sourced at these sites:
 
 
 
electronics-ee.com